DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,679,090 | +88.0% | 6,662 | +98.0% | 0.35% | +50.2% |
| Q4 2022 | $893,138 | -68.9% | 3,365 | -61.4% | 0.23% | -54.7% |
| Q4 2021 | $2,869,000 | +249.9% | 8,721 | +185.4% | 0.51% | +347.0% |
| Q2 2021 | $820,000 | +262.8% | 3,056 | +200.8% | 0.12% | +121.2% |
| Q1 2021 | $226,000 | 0.0% | 1,016 | 0.0% | 0.05% | +2.0% |
| Q4 2020 | $226,000 | -93.9% | 1,016 | -96.2% | 0.05% | -94.7% |
| Q1 2020 | $3,723,000 | +138.2% | 26,900 | +148.6% | 0.96% | +1053.0% |
| Q3 2019 | $1,563,000 | -60.1% | 10,821 | -70.0% | 0.08% | -65.0% |
| Q3 2018 | $3,914,000 | -26.7% | 36,021 | -33.4% | 0.24% | -36.1% |
| Q2 2018 | $5,341,000 | -54.9% | 54,121 | -55.2% | 0.37% | -61.9% |
| Q1 2018 | $11,839,000 | +492.5% | 120,921 | +461.9% | 0.97% | +377.5% |
| Q4 2017 | $1,998,000 | -33.3% | 21,521 | -38.4% | 0.20% | -44.3% |
| Q3 2017 | $2,996,000 | -53.2% | 34,921 | -54.0% | 0.37% | -60.2% |
| Q2 2017 | $6,407,000 | +625.6% | 75,921 | +635.6% | 0.92% | +438.0% |
| Q1 2017 | $883,000 | -58.9% | 10,321 | -62.6% | 0.17% | -60.4% |
| Q4 2016 | $2,150,000 | -29.0% | 27,621 | -28.5% | 0.43% | -51.2% |
| Q3 2016 | $3,028,000 | +21.8% | 38,621 | +56.9% | 0.88% | +3.6% |
| Q2 2016 | $2,487,000 | +184.2% | 24,621 | +167.0% | 0.85% | +129.6% |
| Q1 2016 | $875,000 | +67.6% | 9,221 | +64.0% | 0.37% | +4.8% |
| Q4 2015 | $522,000 | +78.8% | 5,621 | +64.3% | 0.36% | +39.8% |
| Q3 2015 | $292,000 | +14.1% | 3,421 | +13.2% | 0.25% | -40.5% |
| Q1 2015 | $256,000 | +12700.0% | 3,021 | +14285.7% | 0.43% | +14133.3% |
| Q4 2014 | $2,000 | -100.0% | 21 | -99.8% | 0.00% | -99.5% |
| Q3 2014 | $829,778,000 | +434338.7% | 10,921 | +351.1% | 0.64% | +246.2% |
| Q2 2014 | $191,000 | -23.3% | 2,421 | -27.1% | 0.18% | -14.4% |
| Q1 2014 | $249,000 | – | 3,321 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |